S24-099 Precision Immunotherapy: AI-Powered Biomarkers for Predicting Outcomes in Advanced Esophagogastric Cancer Stanford researchers have developed an innovative AI-driven solution for predicting immunotherapy response in esophagogastric cancer patients. Ruijiang Li
S19-500 Early diagnosis and treatment of eye cancer Stanford researchers have applied large-scale proteomic platforms to identify biomarkers that can be used to diagnose uveal melanoma and subtype eye tumors according to their gene expression profile (GEP) class or PRAME status. Gabriel Velez Vinit Mahajan Prithvi Mruthyunjaya